Antibody sequencing

In recent years, as our understanding of antibodies deepens, antibody engineering technologies continue to advance. Techniques such as antibody mass spectrometry sequencing, single-cell sequencing and hybridoma cell sequencing have found widespread applications, providing more tools and avenues for antibody research and applications.

抗体测序服务

Snapkov I, et al. Trends Biotechnol. 2022 

Antibody sequencing addresses many challenges in antibody development. For example, it can be used when certain hybridomas have low expression levels or high-quality antibodies are lost, or when antibodies need to be further modified to enhance their performance. These are all areas where antibody sequencing technologies come into play. Let's take a look at the processes of hybridoma cell sequencing and antibody mass spectrometry sequencing:


Hybridoma Cell Sequencing:

Various methods are currently available for sequencing the variable regions of antibodies from hybridoma cells or lymphocytes. One such method is high-throughput RNA sequencing, which has proven to be highly accurate and enables in-depth analysis of antibody libraries. However, many laboratories may not be familiar with high-throughput sequencing technologies, as they require specialized knowledge in RNA-seq library preparation and computational analysis. Additionally, the cost of high-throughput library preparation and sequencing can be high, and the sequencing turnaround time may range from weeks to months. The mainstream approach to hybridoma cell sequencing involves designing universal primers for amplifying the variable regions of antibody clones from single-cell cultures. This PCR-based method allows for the next-generation sequencing of antibody variable regions, providing information on the antibody gene sequences.

抗体测序服务

Hybridoma cell sequencing process) 

Antibody MS Sequencing

De novo antibody sequencing is a novel method based on high-quality LC-MS/MS spectra for direct sequencing. LC-MS/MS has become the standard technology for new protein sequencing, and capillary electrophoresis provides complementary information for liquid chromatography. It is rapidly evolving as a bottom-up proteomics technique and is widely used in peptide mapping of monoclonal antibodies, comprehensive antibody studies, and analysis of antibody-drug conjugates.

抗体测序服务

(Antibody MS Sequencing process)

Platform features
Easy
Easy

The detection process is convenient, fast and sensitive

Efficient
Efficient

The test will be completed in one week and the experimental results will be delivered

Team
Team

Sample receiving, processing, loading, analysis process is smooth

Compatible
Compatible

Whether expressed in transient or stable cells, batches of stable recombinant antibodies are obtained without interference from animal sources

Data
Data

Complete antibody analysis, test, characterization data report

Service Content

Cycle

Project design
Project design

Preliminary investigation, communication and confirmation

1 day
Sample preparation
Sample preparation

Determine the production volume according to the demand

1-2 day
Sequencing arrangement
Sequencing arrangement

Hybridoma cell sequencing/antimass spectrometry sequencing

1-2 day
Analysis
Analysis

Analysis antibody CDR framework 

1-2 day
Delivery
Delivery

Lab reports, antibody sequence documentation

1 day
Case Show
Antibody A

Antibody A is a target-specific antibody.

Based on the original 100ug antibody, the enzyme-cut sample was sequenced by mass spectrometry, the detection sequence report was delivered in 7 days, the recombinant antibody expression was completed in 2-3 weeks, and the recombinant antibody verification results were consistent with the original antibody.

Antibody A